Vera Therapeutics Inc (VERA)
45.67
+2.23
(+5.13%)
USD |
NASDAQ |
May 06, 15:53
Vera Therapeutics Price to Book Value: 24.46 for May 6, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 03, 2024 | 23.26 |
| May 02, 2024 | 23.29 |
| May 01, 2024 | 22.66 |
| April 30, 2024 | 21.16 |
| April 29, 2024 | 22.16 |
| April 26, 2024 | 21.23 |
| April 25, 2024 | 20.72 |
| April 24, 2024 | 21.39 |
| April 23, 2024 | 21.16 |
| April 22, 2024 | 20.95 |
| April 19, 2024 | 20.35 |
| April 18, 2024 | 21.14 |
| April 17, 2024 | 21.43 |
| April 16, 2024 | 22.80 |
| April 15, 2024 | 24.92 |
| April 12, 2024 | 25.69 |
| April 11, 2024 | 26.14 |
| April 10, 2024 | 22.29 |
| April 09, 2024 | 20.30 |
| April 08, 2024 | 20.69 |
| April 05, 2024 | 20.09 |
| April 04, 2024 | 20.03 |
| April 03, 2024 | 21.21 |
| April 02, 2024 | 21.88 |
| April 01, 2024 | 22.68 |
| Date | Value |
|---|---|
| March 28, 2024 | 23.09 |
| March 27, 2024 | 23.47 |
| March 26, 2024 | 22.27 |
| March 25, 2024 | 22.05 |
| March 22, 2024 | 21.96 |
| March 21, 2024 | 22.96 |
| March 20, 2024 | 24.27 |
| March 19, 2024 | 23.25 |
| March 18, 2024 | 22.21 |
| March 15, 2024 | 22.84 |
| March 14, 2024 | 22.98 |
| March 13, 2024 | 23.89 |
| March 12, 2024 | 23.34 |
| March 11, 2024 | 22.81 |
| March 08, 2024 | 23.40 |
| March 07, 2024 | 22.87 |
| March 06, 2024 | 24.23 |
| March 05, 2024 | 23.85 |
| March 04, 2024 | 24.58 |
| March 01, 2024 | 25.95 |
| February 29, 2024 | 24.87 |
| February 28, 2024 | 24.26 |
| February 27, 2024 | 25.43 |
| February 26, 2024 | 24.48 |
| February 23, 2024 | 25.06 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.715
Minimum
Apr 06 2023
26.14
Maximum
Apr 11 2024
6.376
Average
4.651
Median
Oct 02 2023
Price to Book Value Benchmarks
| Vertex Pharmaceuticals Inc | 5.903 |
| Alpine Immune Sciences Inc | 12.91 |
| Fate Therapeutics Inc | 1.129 |
| Mersana Therapeutics Inc | 11.59 |
| Equillium Inc | 2.811 |
Price to Book Value Related Metrics
| Price | 45.67 |
| Earnings Yield | -5.01% |
| Market Cap | 2.487B |